Skip to main content
. Author manuscript; available in PMC: 2019 Aug 22.
Published in final edited form as: Oncogene. 2018 Dec 5;38(13):2364–2379. doi: 10.1038/s41388-018-0584-6

Fig. 3.

Fig. 3

DHS attenuates dNTP synthesis by downregulating RRM2. a Analysis of dATP production in DHS-treated cells. b dNTP pool assay to examine the synthesis of dATP, dCTP, dGTP, and dTTP in DHS-treated cells for 2 or 24 hours. c Analysis of dATP production in DHS or resveratrol-treated cells. d Cells were harvested after treated with DHS or resveratrol at 10 μM for 20 minutes for Western blotting for indicated proteins.

HHS Vulnerability Disclosure